GaDia is focusing on the development of innovative rapid diagnostic tests for hospitals mainly in the field of infectiology.
With our expertise in developing lateral flow assay (LFA) and rapid test for in vitro diagnostic, GaDia SA can support you in the development of your diagnostic test.
Contact us for more information
R&D Projects
Fungal infection (FungaDia)
On going project for a predictive rapid test for differentiation of fungal healthcare-acquired infections (nosocomial disease).
Bacterial infection (NosoCheck)
Revolutionary test for the detection of sepsis caused by bacteria.
Rapid result to differentiate the cause of infection.
Rapid detection of antibiotic resistance
Parasitic infections (ParaCheck)
Revolutionary test for the detection of parasitic infections in developing countries
Rapid result to differentiate the cause of infection.
Viral Infection – COVID-19 (COVIDia)
COVIDia – Antibody
COVIDia – Antigen
External R&D Projects
Ophthalmology
Gastrointestinal disease and food allergy/intolerance
Scientific publications
Ducrest 2020, Development and evaluation of a new IgM/IgG rapid diagnostic test for SARS-CoV-2
Ducrest et al. 2021, Performance evaluation of the Simtomax®CoronaCheck rapid diagnostic test. Journal of Virological Methods
Ducrest 2021, Development and Evaluation of a new Swiss Made SARS-CoV-2 antigen-detecting rapid test